7664 related articles for article (PubMed ID: 24462553)
1. Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.
Mishra RR; Kneitz S; Schartl M
Comp Biochem Physiol C Toxicol Pharmacol; 2014 Jun; 163():64-76. PubMed ID: 24462553
[TBL] [Abstract][Full Text] [Related]
2. A mutated EGFR is sufficient to induce malignant melanoma with genetic background-dependent histopathologies.
Schartl M; Wilde B; Laisney JA; Taniguchi Y; Takeda S; Meierjohann S
J Invest Dermatol; 2010 Jan; 130(1):249-58. PubMed ID: 19609310
[TBL] [Abstract][Full Text] [Related]
3. Signatures of microRNAs and selected microRNA target genes in human melanoma.
Philippidou D; Schmitt M; Moser D; Margue C; Nazarov PV; Muller A; Vallar L; Nashan D; Behrmann I; Kreis S
Cancer Res; 2010 May; 70(10):4163-73. PubMed ID: 20442294
[TBL] [Abstract][Full Text] [Related]
4. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
[TBL] [Abstract][Full Text] [Related]
5. A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth.
Streicher KL; Zhu W; Lehmann KP; Georgantas RW; Morehouse CA; Brohawn P; Carrasco RA; Xiao Z; Tice DA; Higgs BW; Richman L; Jallal B; Ranade K; Yao Y
Oncogene; 2012 Mar; 31(12):1558-70. PubMed ID: 21860416
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the putative tumor suppressor gene cdkn2ab in pigment cells and melanoma of Xiphophorus and medaka.
Regneri J; Klotz B; Wilde B; Kottler VA; Hausmann M; Kneitz S; Regensburger M; Maurus K; Götz R; Lu Y; Walter RB; Herpin A; Schartl M
Pigment Cell Melanoma Res; 2019 Mar; 32(2):248-258. PubMed ID: 30117276
[TBL] [Abstract][Full Text] [Related]
7. Germ cell and tumor associated piRNAs in the medaka and Xiphophorus melanoma models.
Kneitz S; Mishra RR; Chalopin D; Postlethwait J; Warren WC; Walter RB; Schartl M
BMC Genomics; 2016 May; 17():357. PubMed ID: 27183847
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional background effects on a tumor driver gene in different pigment cell types of medaka.
Abdulsahib S; Boswell W; Boswell M; Savage M; Schartl M; Lu Y
J Exp Zool B Mol Dev Evol; 2024 May; 342(3):252-259. PubMed ID: 37877158
[TBL] [Abstract][Full Text] [Related]
9. Expression signatures of early-stage and advanced medaka melanomas.
Klotz B; Kneitz S; Regensburger M; Hahn L; Dannemann M; Kelso J; Nickel B; Lu Y; Boswell W; Postlethwait J; Warren W; Kunz M; Walter RB; Schartl M
Comp Biochem Physiol C Toxicol Pharmacol; 2018 Jun; 208():20-28. PubMed ID: 29162497
[TBL] [Abstract][Full Text] [Related]
10. Genomic organization and embryonic expression of miR-430 in medaka (Oryzias latipes): insights into the post-transcriptional gene regulation in early development.
Tani S; Kusakabe R; Naruse K; Sakamoto H; Inoue K
Gene; 2010 Jan; 449(1-2):41-9. PubMed ID: 19770025
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA miR-125b induces senescence in human melanoma cells.
Glud M; Manfé V; Biskup E; Holst L; Dirksen AM; Hastrup N; Nielsen FC; Drzewiecki KT; Gniadecki R
Melanoma Res; 2011 Jun; 21(3):253-6. PubMed ID: 21460750
[TBL] [Abstract][Full Text] [Related]
12. Regulation of CDKN2A/B and Retinoblastoma genes in Xiphophorus melanoma.
Butler AP; Trono D; Coletta LD; Beard R; Fraijo R; Kazianis S; Nairn RS
Comp Biochem Physiol C Toxicol Pharmacol; 2007 Feb; 145(1):145-55. PubMed ID: 17011832
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs in melanoma biology.
Kunz M
Adv Exp Med Biol; 2013; 774():103-20. PubMed ID: 23377970
[TBL] [Abstract][Full Text] [Related]
14. Expression regulation triggers oncogenicity of xmrk alleles in the Xiphophorus melanoma system.
Regneri J; Schartl M
Comp Biochem Physiol C Toxicol Pharmacol; 2012 Jan; 155(1):71-80. PubMed ID: 21527356
[TBL] [Abstract][Full Text] [Related]
15. Xmrk in medaka: a new genetic melanoma model.
Patton EE; Nairn RS
J Invest Dermatol; 2010 Jan; 130(1):14-7. PubMed ID: 20010863
[TBL] [Abstract][Full Text] [Related]
16. Generating and analyzing fish models of melanoma.
Patton EE; Mathers ME; Schartl M
Methods Cell Biol; 2011; 105():339-66. PubMed ID: 21951537
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA expression profiles associated with mutational status and survival in malignant melanoma.
Caramuta S; Egyházi S; Rodolfo M; Witten D; Hansson J; Larsson C; Lui WO
J Invest Dermatol; 2010 Aug; 130(8):2062-70. PubMed ID: 20357817
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-221 and -222 pathway controls melanoma progression.
Felicetti F; Errico MC; Segnalini P; Mattia G; Carè A
Expert Rev Anticancer Ther; 2008 Nov; 8(11):1759-65. PubMed ID: 18983236
[TBL] [Abstract][Full Text] [Related]
19. miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells.
Dynoodt P; Speeckaert R; De Wever O; Chevolet I; Brochez L; Lambert J; Van Gele M
Int J Oncol; 2013 Apr; 42(4):1443-51. PubMed ID: 23404256
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression.
Kappelmann M; Kuphal S; Meister G; Vardimon L; Bosserhoff AK
Oncogene; 2013 Jun; 32(24):2984-91. PubMed ID: 22797068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
